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Previewsachieved by targeted optogenetic activa-
tion of a single interneuron axon, or via
GABA uncaging. Finally, the precise inhi-
bition of backpropagating action poten-
tials in dendrites observed by Mu¨llner
et al. (2015) highlights the importance of
controlling bAPs as a key mechanism in
certain forms of synaptic plasticity. In
particular, during STDP the backpropa-
gating AP tells dendritic synapses
whether they contributed successfully to
generating the postsynaptic AP, imple-
menting Hebb’s rule. The findings by
Mu¨llner et al. (2015) therefore make an
important prediction: synaptic plasticity
can be regulated by a single inhibitory
synapse. With precise spatial and tempo-
ral modulation of Ca2+-transient inhibition,
plasticity could be vetoed very locally in
individual dendritic branches, facilitating
storage of new patterns of synaptic
weights in some branches while prevent-
ing the weights of synapses on the in-
hibited dendritic branch from being468 Neuron 87, August 5, 2015 ª2015 Elsevioverwritten. To test this prediction, future
experiments could explore whether plas-
ticity induction can be blocked specif-
ically in dendritic branches contacted by
individual inhibitory contacts, but not in
nearby branches. Together, these experi-
ments will help to show how single inhibi-
tory synapses, like Bard the Bowman’s
arrow, can have an unexpectedly power-
ful influence on their targets, on both brief
and longer timescales.REFERENCES
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Norepinephrine and corticotropin-releasing hormone (CRH) have long been implicated in the response to
stress. In this issue ofNeuron, McCall et al. (2015) show that CRH projections from the central amygdala drive
tonic locus coeruleus activity that evokes acute anxiety responses and place aversion.Fear and anxiety describe particular
mental states that are accompanied by
characteristic features of vigilance, avoid-
ance, and physiological arousal. These
features are seen in all animals and have
evolved as a mechanism to adapt to aver-
sive or stressful conditions. While clearly
having adaptive value, excessive anxiety
is maladaptive and can interfere with
normal life. The Diagnostic and Statistical
Manual of the American Psychiatric Asso-ciation (DSM) has classified maladaptive
anxiety into a number of mental disorders,
such as generalized anxiety, panic disor-
der, and posttraumatic stress (DSM 5,
2013). It is estimated that these disorders
affect up to 20% of the population at
some time during their lifetime, and the
overall health cost to the community is
enormous. A growing body of literature
has begun to elucidate the neural circuits
that mediate both fear and anxiety, and itis clear that these two interrelated states
arise from neural circuits that are distinct
but which also share common elements.
For example, these studies have shown
that both fear and anxiety require the
amygdalar complex, and recent studies
show that they also engage a wide and
complex network including the extended
amygdala, hippocampus, and lateral
septum (Tovote et al., 2015). Studies to
date have concentrated on the circuits
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Previewsthat engage rapid signaling. However,
anxiogenic responses have long been
known to engage complex neuromodula-
tory systems, and many current therapies
for anxiety disorders are based on this ac-
tivity. In particular, the neuromodulators
corticotropin-releasing hormone (CRH)
and norepinephrine (NE) have long been
implicated (Joe¨ls et al., 2011; Koob,
1999). While CRH is known to modulate
the activity of noradrenergic neurons in
the locus coeruleus (LC), the source of
CRH, and how these two systems
interact, has not been clear. In this issue
ofNeuron, McCall and colleagues (McCall
et al., 2015) have examined anxiety
induced by acute restraint stress to study
the role of the LC and its modulation by
CRH. Using a combination of optoge-
netics, circuit tracing, and behavioral
analysis, they show that CRH released in
the LC by central amygdala afferents
evokes high-frequency activity in LC
neurons, following which synaptically
released norepinephrine leads to stress-
induced anxiety and aversion. These re-
sults are an important step forward in
our understanding of the brain circuitry
and endogenous neuromodulators medi-
ating negative affective behaviors, and
open theway to the development of better
prevention and treatment of anxiety-
related disorders.
The LC, a nucleus in the brain stem, is
one of the principal sites for brain synthe-
sis of NE (a process that requires tyrosine
hydroxylase, TH). These neurons project
widely throughout the neuraxis and are
known to be involved in a range of
stress-related responses such as anxiety,
depression, and posttraumatic stress
(Sara, 2009). Using expression of the im-
mediate-early gene c-fos, the authors
first show that 30 min of restraint stress
activates noradrenergic neurons in the
LC. Previous studies have shown that
nonselective pharmacological inactiva-
tion or lesions of the LC can disrupt
aversive responses; however, the precise
mechanism and function of LC-NE neu-
rons in stress-induced negative affective
behaviors has remained largely unknown.
Using TH-CRE mice to selectively ex-
press the DREADD hM4Di in LC-NE neu-
rons, the authors show that silencing
these neurons effectively abrogates acute
stress-induced anxiety as assessed using
the open field test (OFT), thus showingthat activity of LC neurons is necessary
for this response.
In awake animals, LC neurons show
distinct patterns of activity, with low-fre-
quency (1–2 Hz) tonic activity observed
in resting and alert states, shifting to
high-frequency (3–8 Hz) mode in res-
ponse to distinct, salient sensory stimuli,
which has been suggested to be related
to stressful events (Valentino and Van
Bockstaele, 2008). Using optogenetic
activation of LC neurons, they show that
tonic 5 Hz stimulation reproduced the
anxiogenic effects of acute stress, while
low-frequency (1–2 Hz) stimulation was
ineffective. These effects were apparent
not only during the stimulation but also
30–50 min after the stimulation. Thus an
increase in LC-NE neuron activity, without
a physical stressor, was itself anxiogenic.
Using a Pavlovian conditioned place
aversion assay, they show that high-fre-
quency tonic activity of LC-NE neurons
also has a negative valence with long-
lasting effects, demonstrating that LC ac-
tivity results in learning that influenced
future behavior. The LC projects widely
throughout the CNS, and different types
of stress, e.g., hypotensive shock, foot-
shock, etc., are known to activate neu-
rons in the LC (Chen and Sara, 2007). As
neurons in the LC are strongly electrically
coupled (Christie et al., 1989), it has
often been viewed as a homogeneous
structure mediating its actions via wide-
spread projections. Interestingly, the
authors find that the effects of LC stimula-
tion on acute anxiogenic responses were
blocked by the b-adrenoceptor antago-
nist propranolol, whereas the aversive ef-
fects during conditioned place preference
required a1-adrenoceptor activity, sug-
gesting that acute stress-induced anxiety
and aversive behaviors are driven by
distinct circuits.
CRH is broadly distributed throughout
the central nervous system, and its
release in the LC is thought to increase
LC neural activity to produce stress-
induced anxiogenesis (Stenzel-Poore
et al., 1994). The source of CRH in this
response has been suggested to be LC-
projecting neurons in the central amyg-
dala (Curtis et al., 2002). To test the causal
role of CeA-CRH in LC-NE activity-depen-
dent aversion and anxiety-like behaviors,
the authors first confirmed CeA CRH
input into the LC using two retrogradeNeuron 8tracing approaches. Next, using another
CRE-line (CRH-CRE) to express chan-
nelrhodopsin (ChR2) in CRH-expressing
neurons in the CeA, they show that high-
frequency (5–10 Hz) tonic stimulation of
these terminals is capable of driving aver-
sion and anxiety-like behaviors similar to
direct LC-NE stimulation or stress alone.
Furthermore, the anxiogenic phenotype
was completely reversed by CRH recep-
tor antagonism, demonstrating a causal
relationship between CRH release from
CeA-LC terminals and LC-NE neuron
tonic activity in stress-induced negative
affective behaviors.
These results show that the anxiogenic
effects of acute stress are mediated by
the activity of CRH-containing neurons in
the CeA, and release of CRH in the LC.
However, as with many studies, it also rai-
ses a number of questions. The authors
show that photostimulation of CeA-LC
CRH terminals in the LC had diverse ac-
tions: increasing the activity of nearly
half the cells, but reducing the activity of
some. The precise nature of these diverse
actions remains unclear, but suggests
that specific populations of neurons in
the LC may be engaged during different
responses. In agreement with this, acute
anxiogenic effects of LC stimulation re-
quired b-adrenergic activity while condi-
tioned place aversion resulted from
a-adrenoceptor activity, indicating that
different sets of LC projections mediate
these two behavioral effects. Moreover,
optically stimulating galanin-expressing
neurons in the LC, which form a distinct
population of LC-NE neurons, can repro-
duce the aversive response similar to
that induced by whole LC-NE tonic stimu-
lation. This result suggests that distinct
populations of LC neurons may trigger
aversive responses (Figure 1). It would
be interesting to see if the aversive
response to activation of galanin-ex-
pressing neurons also required a-adreno-
ceptors, and whether these neurons
could also evoke acute anxiogenic
responses.
This study identifies CRH-containing
projections from the CeA to the LC.
Previous immunohistochemical studies
have shown that CRH neurons are largely
present in the lateral central amygdala
(CeL) (Asan et al., 2005). Within the CeL,
protein kinase C-d (PKC-d) and somato-
statin (SOM)-expressing neurons play7, August 5, 2015 ª2015 Elsevier Inc. 469
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Figure 1. Stress-Induced Tonic Activity in the Locus Coeruleus
Stress-induced tonic activity in the locus coeruleus (LC) is driven by CRH inputs from the central amygdala
(CeA), evoking acute anxiety and aversive place avoidance. Schematic networks show projections be-
tween the CeA and LC, and widespread projections from the LC.
(A) In the resting state, CeA to LC afferents are silent, and neurons in the LC discharge at low frequency.
(B) In response to stress, CeA afferents release corticotropin-releasing hormone (CRH) in the LC, thus shift-
ing their discharge to higher frequencies. Projections from the LC that generate acute anxiety (red) activate
b-adrenoceptors, whereas projections that signal negative valence (blue) activate a-adrenoreceptors. One
possibility (left) is that the same LC projections are activated under both acute anxiety and aversive
response, and different receptors are engaged in the relevant structures. Alternatively (right), distinct LC
projections may be activated in the two states, with different projections targeting different receptors.
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Previewskey roles in the coding of ‘‘phasic fear’’
assessed using cue-dependent Pavlovian
fear conditioning. As some CRH neurons
(16.9%) coexpress PKC-d (Haubensak
et al., 2010), separation of circuits in the
CeL that mediate phasic versus tonic
fear (anxiety) will be required to distin-
guish the neural systems that drive anxi-
ety and phasic fear. The McCall et al.
(2015) study highlights the power of using
transgenic lines and optogenetic tech-
niques to understand the neural circuits
that underpin specific behavioral out-
comes. The LC innervates all the centers
that have been implicated in anxiogenic
and aversive behaviors (Sara, 2009), and
even within the amygdala a- and b-adre-
noceptors can have distinct actions
(Delaney et al., 2007; Faber et al., 2008).470 Neuron 87, August 5, 2015 ª2015 ElseviThus, understanding the different target
regions that mediate anxiogenesis and
aversive behaviors is necessary to disen-
tangle the distinct roles of a and b-adre-
noceptors. What is exciting for the future
is that results from circuit analyses
(Schwarz et al., 2015) in conjunction with
the rapidly developing genomics of neu-
ropsychiatric disorders will lead to the
establishment of biological markers for
more objective diagnoses of psychiatric
diseases. This should in turn spur new
treatment strategies based on the target-
ing of disorder-specific neuronal circuits.ACKNOWLEDGMENTS
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